AR052885A1 - Metodos para el control del intervalo qt - Google Patents
Metodos para el control del intervalo qtInfo
- Publication number
- AR052885A1 AR052885A1 ARP060100224A ARP060100224A AR052885A1 AR 052885 A1 AR052885 A1 AR 052885A1 AR P060100224 A ARP060100224 A AR P060100224A AR P060100224 A ARP060100224 A AR P060100224A AR 052885 A1 AR052885 A1 AR 052885A1
- Authority
- AR
- Argentina
- Prior art keywords
- phenyl
- alkyl
- group
- subject
- optionally substituted
- Prior art date
Links
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 239000011737 fluorine Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 210000001308 heart ventricle Anatomy 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 229910052740 iodine Inorganic materials 0.000 abstract 1
- 239000011630 iodine Substances 0.000 abstract 1
- 230000028161 membrane depolarization Effects 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 230000002336 repolarization Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Métodos para controlar la duracion de la despolarizacion y repolarizacion del ventrículo cardíaco y por lo tanto del intervalo QT, en formas terapéuticamente utiles en un sujeto, que comprende administrar al sujeto con necesidad de ello, una cantidad terapéuticamente efectiva de un compuesto seleccionado del grupo que incluye formula (1) y formula (2), o una sal aceptable para uso farmacéutico o un éster del mismos, donde fenilo está sustituido en X con uno a cinco átomos de halogeno seleccionados del grupo que incluye fluor, cloro, bromo y yodo; y R1, R2, R3, R4, R5 y R6 son seleccionados independientemente del grupo que incluye hidrogeno y alquilo C1-4; donde alquilo C1-4 está sustituido opcionalmente con fenilo, donde fenilo está sustituido opcionalmente con sustituyentes seleccionados independientemente del grupo que incluye halogeno, alquilo C1-4, alcoxi C1-4, amino, nitro y ciano.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64544705P | 2005-01-20 | 2005-01-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR052885A1 true AR052885A1 (es) | 2007-04-11 |
Family
ID=36147919
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP060100224A AR052885A1 (es) | 2005-01-20 | 2006-01-20 | Metodos para el control del intervalo qt |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US7846968B2 (es) |
| EP (1) | EP1850841A1 (es) |
| JP (1) | JP2008528489A (es) |
| KR (1) | KR20080025034A (es) |
| CN (1) | CN101146527A (es) |
| AR (1) | AR052885A1 (es) |
| AU (1) | AU2006206778A1 (es) |
| BR (1) | BRPI0606484A2 (es) |
| CA (1) | CA2595599A1 (es) |
| CR (1) | CR9322A (es) |
| EA (1) | EA200701536A1 (es) |
| IL (1) | IL184730A0 (es) |
| MX (1) | MX2007008845A (es) |
| NO (1) | NO20074175L (es) |
| NZ (1) | NZ556497A (es) |
| TW (1) | TW200637540A (es) |
| WO (1) | WO2006078524A1 (es) |
| ZA (1) | ZA200706916B (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4719890B2 (ja) * | 2006-11-09 | 2011-07-06 | 国立大学法人三重大学 | トルサード・ド・ポアンツ型心室頻拍を呈するゼブラフィッシュ |
| CZ2007376A3 (cs) * | 2007-05-30 | 2008-12-10 | Ústav prístrojové techniky AV CR, v.v.i. | Zpusob analýzy ventrikulární repolarizace |
| US9538933B2 (en) * | 2007-09-12 | 2017-01-10 | Koninklijke Philips N.V. | QT interval monitoring system with alarms and trending |
| US8019406B2 (en) * | 2008-03-10 | 2011-09-13 | Biotronik Crm Patent Ag | Apparatus and method to assess the risk of R-on-T event |
| FR2953410B1 (fr) * | 2009-12-09 | 2012-02-24 | Univ Claude Bernard Lyon | Compositions antivirales pharmaceutiques ou veterinaires |
| US8609849B1 (en) | 2010-11-30 | 2013-12-17 | Fox Chase Chemical Diversity Center, Inc. | Hydroxylated sulfamides exhibiting neuroprotective action and their method of use |
| CN105497876B (zh) | 2014-09-24 | 2021-01-15 | 上海泽生科技开发股份有限公司 | 神经调节蛋白用于预防、治疗或延迟心脏室性心律失常的方法和组合物 |
| JP6954582B2 (ja) * | 2016-12-22 | 2021-10-27 | 国立大学法人滋賀医科大学 | 医薬組成物 |
| US11610660B1 (en) | 2021-08-20 | 2023-03-21 | AltaThera Pharmaceuticals LLC | Antiarrhythmic drug dosing methods, medical devices, and systems |
| US11696902B2 (en) | 2018-08-14 | 2023-07-11 | AltaThera Pharmaceuticals, LLC | Method of initiating and escalating sotalol hydrochloride dosing |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3313692A (en) * | 1958-04-21 | 1967-04-11 | Armour Pharma | Method of inducing calming and muscle relaxation with carbamates |
| US3265728A (en) * | 1962-07-18 | 1966-08-09 | Armour Pharma | Substituted phenethyl carbamates |
| US5698588A (en) * | 1996-01-16 | 1997-12-16 | Yukong Limited | Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol |
| BR0112713A (pt) * | 2000-07-21 | 2003-07-22 | Ortho Mcneil Pharm Inc | "compostos de carbamato para uso na prevenção ou tratamento de dor neuropática e dor associada a cefaléia em cacho e hemicrânia |
| RS50505B (sr) | 2001-02-27 | 2010-03-02 | Ortho-Mcneil Pharmaceutical Inc. | Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju anksioznih poremećaja |
-
2006
- 2006-01-11 EA EA200701536A patent/EA200701536A1/ru unknown
- 2006-01-11 CA CA002595599A patent/CA2595599A1/en not_active Abandoned
- 2006-01-11 EP EP06718114A patent/EP1850841A1/en not_active Withdrawn
- 2006-01-11 BR BRPI0606484-1A patent/BRPI0606484A2/pt not_active IP Right Cessation
- 2006-01-11 MX MX2007008845A patent/MX2007008845A/es unknown
- 2006-01-11 CN CNA2006800089860A patent/CN101146527A/zh active Pending
- 2006-01-11 NZ NZ556497A patent/NZ556497A/en not_active IP Right Cessation
- 2006-01-11 JP JP2007552172A patent/JP2008528489A/ja active Pending
- 2006-01-11 US US11/329,757 patent/US7846968B2/en not_active Expired - Fee Related
- 2006-01-11 KR KR1020077018992A patent/KR20080025034A/ko not_active Application Discontinuation
- 2006-01-11 WO PCT/US2006/001000 patent/WO2006078524A1/en active Application Filing
- 2006-01-11 AU AU2006206778A patent/AU2006206778A1/en not_active Abandoned
- 2006-01-19 TW TW095101996A patent/TW200637540A/zh unknown
- 2006-01-20 AR ARP060100224A patent/AR052885A1/es not_active Application Discontinuation
-
2007
- 2007-07-19 IL IL184730A patent/IL184730A0/en unknown
- 2007-08-14 NO NO20074175A patent/NO20074175L/no not_active Application Discontinuation
- 2007-08-17 ZA ZA200706916A patent/ZA200706916B/xx unknown
- 2007-08-17 CR CR9322A patent/CR9322A/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2006206778A1 (en) | 2006-07-27 |
| EP1850841A1 (en) | 2007-11-07 |
| WO2006078524A1 (en) | 2006-07-27 |
| BRPI0606484A2 (pt) | 2009-06-30 |
| CN101146527A (zh) | 2008-03-19 |
| ZA200706916B (en) | 2009-04-29 |
| JP2008528489A (ja) | 2008-07-31 |
| CA2595599A1 (en) | 2006-07-27 |
| MX2007008845A (es) | 2007-11-08 |
| IL184730A0 (en) | 2008-08-07 |
| NO20074175L (no) | 2007-10-11 |
| US7846968B2 (en) | 2010-12-07 |
| EA200701536A1 (ru) | 2008-02-28 |
| NZ556497A (en) | 2011-03-31 |
| CR9322A (es) | 2008-09-09 |
| TW200637540A (en) | 2006-11-01 |
| KR20080025034A (ko) | 2008-03-19 |
| US20070010578A1 (en) | 2007-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR052885A1 (es) | Metodos para el control del intervalo qt | |
| AR054551A1 (es) | Metodos para la neuroproteccion | |
| AR054524A1 (es) | Metodos y formas de dosificacion para reducir los efectos secundarios de compuestos de carbamato | |
| AR054550A1 (es) | Metodos para tratar la epileptogenesis | |
| CO6180427A2 (es) | Tratamiento de los trastornos generalizados del desarrollo | |
| PE20080552A1 (es) | Derivados de alcoholes 1-fenil-2-piridinil alquilenicos como inhibidores de fosfodiesterasa | |
| PE20070218A1 (es) | COMPUESTOS DE CICLOALQUILO AMINO-HIDANTOINA Y USO DE ESTOS PARA LA MODULACION DE ß-SECRETASA | |
| DK1809273T3 (da) | Anvendelse af 2-phenyl-1,2-ethandiol-(di)carbamater til behandling af epileptogenese | |
| AR072952A1 (es) | Compuestos de 2-imino-3-metilpirrolopirimidinona fenilo-sustituida como inhibidores de bace-1, composiciones y su uso | |
| PE20060691A1 (es) | Serinamidas sustituidas por benzoilo | |
| WO2003106428A8 (fr) | Derives d'arylsulfonamides et leur utilisation en tant que antagonistes au recepteur b1 de la bradykinine | |
| PE20100737A1 (es) | Nuevos compuestos | |
| AR054386A1 (es) | Moduladores de quinasas con estructuras de alquiloquinolina y alquilquinazolina | |
| AR033426A1 (es) | Uso de compuestos carbamatos en la prevencion o el tratamiento de trastornos de movimiento | |
| AR064241A1 (es) | Metodos para el tratamiento de la depresion | |
| ECSP077395A (es) | Compuesto de carbamato para utilizar en el tratamiento de padecimientos neurodegenerativos | |
| AR033427A1 (es) | Uso de compuestos carbamatos en el tratamiento del dolor | |
| MXPA03007717A (es) | Compuestos de carbamato para su uso en la prevencion o tratamiento de trastornos bipolares. | |
| CO6180505A2 (es) | Metodos para el tratamiento de transtornos cocleares y vestibulares | |
| CO6160292A2 (es) | Metodos de tratamiento de transtornos de comportamiento perturbador 877 | |
| AR034785A1 (es) | Compuestos de carbamato para utilizarse en la prevencion o tratamiento de dolor neuropatico y dolor asociado con cefalea migranosa y cefalea acuminada | |
| AR032907A1 (es) | Uso de compuestos carbamatos para la prevencion o tratamiento de trastornos de ansiedad | |
| UY29158A1 (es) | Metodos de tratamiento de la epileptogénesis y la epilepsia | |
| AR033428A1 (es) | Compuestos carbamatos para su uso en la prevencion o tratamiento de trastornos bipolares | |
| AR051449A1 (es) | Compuestos derivados de 1-3 bencimidazoles, composiciones que lo contienen, preparacion y usos de los mismos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |